pre-update Archives

Publication

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

A FRIENDS OF CANCER RESEARCH WHITE PAPER The article explores the complex landscape of determining…

CertaraDecember 19, 2023

On-Demand Webinar

Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment

Secondary pharmacology profiling involves the screening of small molecule compounds against a broad range of…

CertaraDecember 19, 2023

On-Demand Webinar

Survival of the Fittest: Evolving Pharmacokinetic Modeling with Pirana

As regulatory acceptance of models for decision-making grows, so too does the need for optimally…

CertaraDecember 19, 2023

Blog

Answers to Drug Developers’ Frequent Electronic Common Technical Document Questions

Although the Electronic Common Technical Document (eCTD) has been around for many years, it continues…

CertaraDecember 12, 2023

Fact Sheet

Attain FDA Label Claims for Kinase Inhibitor Drugs with the Simcyp™ Simulator

Simcyp was used by pharma and biotech companies to inform, reduce and/or replace clinical studies…

CertaraDecember 6, 2023

Press Coverage

Pharma Focus Europe – Issue 03 – Using AI to Accelerate Drug Development

Authors: Professor Amin Rostami-Hodjegan, Professor Piet van der Graaf This Pharma Focus EU article, co-authored…

CertaraDecember 5, 2023

Announcement

Certara Launches Updated Version of Pirana Modeling Workbench

PRINCETON, N.J.— December 1, 2023 – Certara, Inc., a global leader in biosimulation, today announced…

CertaraDecember 1, 2023

Publication

Model-informed target identification and validation through combining quantitative systems pharmacology with network-based analysis

Authors: Vijayalakshmi Chelliah, Piet H. van der Graaf One of the main areas where quantitative…

CertaraNovember 28, 2023

Publication

Creation of novel sensitive probe substrate and moderate inhibitor models for a comprehensive prediction of CYP2C8 interactions for tucatinib

Authors: Ian E. Templeton, Karen Rowland-Yeo, Hannah M. Jones, Christopher J. Endres, Ariel R. Topletz-Erickson, Hao Sun, Anthony J. Lee A…

CertaraNovember 28, 2023

Press Release

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex…

CertaraNovember 21, 2023

pre-update

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

Off-Target Drug Safety: Replacing Educated Guesswork with Evidence-Based Risk Assessment

Survival of the Fittest: Evolving Pharmacokinetic Modeling with Pirana

Answers to Drug Developers’ Frequent Electronic Common Technical Document Questions

Attain FDA Label Claims for Kinase Inhibitor Drugs with the Simcyp™ Simulator

Pharma Focus Europe – Issue 03 – Using AI to Accelerate Drug Development

Certara Launches Updated Version of Pirana Modeling Workbench

Model-informed target identification and validation through combining quantitative systems pharmacology with network-based analysis

Creation of novel sensitive probe substrate and moderate inhibitor models for a comprehensive prediction of CYP2C8 interactions for tucatinib

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

Newsletter sign up

Quick links

Solutions

Contact